TARS · Forms 3, 4, 5

Insider trades at Tarsus Pharmaceuticals, Inc.

4 insiders sold $5.2M of Tarsus Pharmaceuticals, Inc. stock on the open market in the last 90 days.

Every Form 3, 4 and 5 filed for Tarsus Pharmaceuticals, Inc. (TARS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
David E I PyottDirectorOption exercise201Form 4
Wendy L YarnoDirectorOption exercise302Form 4
William J Phd LinkDirectorOption exercise201Form 4
William J Phd LinkDirectorSell11,675$78.33$915KForm 4
William J Phd LinkDirectorSell759$79.00$60KForm 4
William J Phd LinkDirectorSell66$80.01$5KForm 4
Bobak R. AzamianPresident/CEO and Board ChairSell7,100$90.27$641KForm 4
Bobak R. AzamianPresident/CEO and Board ChairSell2,900$91.27$265KForm 4
Elizabeth Yeu LinChief Medical OfficerSell5,387$85.00$458KForm 4
Elizabeth Yeu LinChief Medical OfficerSell5,386$90.00$485KForm 4
Elizabeth Yeu LinChief Medical OfficerSell1,590$85.00$135KForm 4
Elizabeth Yeu LinChief Medical OfficerSell1,590$90.00$143KForm 4
Seshadri NeervannanChief Operating OfficerSell4,564$85.00$388KForm 4
Bobak R. AzamianPresident/CEO and Board ChairSell10,000$80.06$801KForm 4
Elizabeth Yeu LinChief Medical OfficerSell5,387$80.00$431KForm 4
Elizabeth Yeu LinChief Medical OfficerSell1,590$80.00$127KForm 4
Elizabeth Yeu LinChief Medical OfficerSell4,601$73.86$340KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.